206 related articles for article (PubMed ID: 7310781)
21. Detection and characterization of circulating immune complexes in rheumatoid arthritis.
Wattre P; Santoro F; Bout D; Defrance D; Capron A
Biomedicine; 1976 Sep; 25(7):249-51. PubMed ID: 990384
[TBL] [Abstract][Full Text] [Related]
22. [The role of circulating immune complexes in children with rheumatoid arthritis].
Ulanova MA; Iandashevskaia SI; Aleshkin VA; Ponomareva AM; Saatova GM
Revmatologiia (Mosk); 1989; (4):42-8. PubMed ID: 2637464
[TBL] [Abstract][Full Text] [Related]
23. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.
Mallya RK; Vergani D; Tee DE; Bevis L; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
Clin Exp Immunol; 1982 Jun; 48(3):747-53. PubMed ID: 6981476
[TBL] [Abstract][Full Text] [Related]
24. [Beta2 microglobulin, antibeta2 microglobulin activity and circulating immune complexes in rheumatoid arthritis. Serum and synovial study].
Duquesnoy B; Asfour M; Santoro F; Vandemeulebroucke B; Hochart JP; Delcambre B
Rev Rhum Mal Osteoartic; 1980; 47(7-9):481-7. PubMed ID: 6158754
[TBL] [Abstract][Full Text] [Related]
25. Reticuloendothelial function in rheumatoid arthritis: correlation with disease activity and circulating immune complexes.
Henderson JM; Bell DA; Harth M; Chamberlain MJ
J Rheumatol; 1981; 8(3):486-9. PubMed ID: 7288766
[TBL] [Abstract][Full Text] [Related]
26. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
28. [Various quantitative and qualitative characteristics of circulating immune complexes in rheumatic vasculitis].
Matulis AA; Venalis AI; Mishkinite GA; Tamuliavichene IV; Karlene VS
Ter Arkh; 1985; 57(8):72-5. PubMed ID: 2416074
[TBL] [Abstract][Full Text] [Related]
29. Defective serum chemotactic capacity in rheumatoid arthritis.
Attia WM; Ali MK; Abu-Ghazalah LM; Shams AH; Clark HW; Brown TM; Bellanti JA
Ann Allergy; 1983 Apr; 50(4):266-70. PubMed ID: 6838025
[TBL] [Abstract][Full Text] [Related]
30. Anti-globulins and circulating complexes in early rheumatoid arthritis.
Hay FC; Young A; Jones MG; Nineham LJ; Male DK; Roitt IM
Clin Exp Immunol; 1983 Dec; 54(3):723-30. PubMed ID: 6606514
[TBL] [Abstract][Full Text] [Related]
31. Circulating immune complexes in patients with diabetes mellitus.
Abrass CK; Heber D; Lieberman J
Clin Exp Immunol; 1983 Apr; 52(1):164-72. PubMed ID: 6305541
[TBL] [Abstract][Full Text] [Related]
32. [Serum immune complexes in rheumatoid arthritis (a study of 100 cases). Comparison of the results obtained by four different detection techniques].
Piton JL; Alibeu C; Renversez JC; Chenais F; Tournoud A; Dodelier C; Phelip X; Cabanel G
Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):9-18. PubMed ID: 6342115
[TBL] [Abstract][Full Text] [Related]
33. Circulating immune complexes and complement in rheumatoid arthritis.
Duquesnoy B
Ann Biol Clin (Paris); 1984; 42(1):71-5. PubMed ID: 6375473
[TBL] [Abstract][Full Text] [Related]
34. [Rheumatoid factors, C-reactive protein and circulating immunocomplexes: laser-nephelometric determination using the latex aggregation method. Preliminary evaluation in rheumatoid arthritis].
Bartoloni C; Guidi L; Tricerri A; Baroni R; Pellegrino M; Scrimieri D; Gambassi G
Minerva Med; 1987 Dec; 78(23):1775-8. PubMed ID: 3696453
[TBL] [Abstract][Full Text] [Related]
35. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of C1q - binding to collagen - anticollagen immune complexes in synovial fluids of RA-patients.
Menzel J; Steffen C
Z Rheumatol; 1982; 41(2):47-9. PubMed ID: 6285637
[TBL] [Abstract][Full Text] [Related]
37. Reticuloendothelial system fc receptor function in rheumatoid arthritis.
Fields TR; Gerardi EN; Ghebrehiwet B; Bennett RS; Lawley TJ; Hall RP; Plotz PH; Karsh JR; Frank MM; Hamburger MI
J Rheumatol; 1983 Aug; 10(4):550-7. PubMed ID: 6620262
[TBL] [Abstract][Full Text] [Related]
38. Circulating immune complexes detected by C1q solid phase assay in leprosy.
Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
[TBL] [Abstract][Full Text] [Related]
39. Loss of suppressor T cell function and circulating immune complexes in alcoholic cirrhosis.
Echevarría S; San Miguel G; Rodríguez de Lope C; Castillo E; Pons Romero F
Allergol Immunopathol (Madr); 1985; 13(5):405-10. PubMed ID: 2934964
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of serum IgA levels with serum IgG levels, erythrocyte sedimentation rate and platelet counts in 98 patients with rheumatoid arthritis].
Nishiya K; Tahara K; Matsumori A; Chijiwa T; Hashimoto K
Rinsho Byori; 1999 Jul; 47(7):665-8. PubMed ID: 10442046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
